News Snapshot:
During the global scramble to secure vaccines, many countries in Asia-Pacific were slow off the mark. This time, they’re not making the same mistake. Countries around the region are rushing to place orders for the latest weapon against Covid-19: an antiviral pill that isn’t even authorized for use yet. Molnupiravir — produced by US pharmaceutical company Merck — is being heralded as a potential pandemic game changer, especially for those unable to get vaccinated. Merck is seeking US Food and Drug Administration emergency use authorization for the drug — and if it’s granted, the capsule will become the first oral...
